Insilicogen Launches Promotion: "Share One and Conduct Research All Year Round"

Free Distribution of Molecular Biology Data Integration Analysis Software
"To Provide Convenience and Usefulness in Nucleotide Sequence Analysis Research"

Insilicogen, a bioinformatics specialist company contributing to the advancement of digital breeding in Korea, announced on the 11th that it is conducting a promotion called “Share One and Conduct Smooth Research All Year Long!” which offers free distribution of CLC Main Workbench, a GUI-based sequence molecular biology data integrated analysis software.

This promotion, available for application until May 24, is part of a digital transformation campaign for bioinformatics research labs. Participants who write and share biology-related knowledge articles on the bioinformatics specialized wiki Incodom (www.incodom.kr) or create and share biology-related knowledge shorts videos by June 30 will receive a free 1-year license of CLC Main Workbench.

CLC Main Workbench is a bioinformatics software that enables sequence data analysis with just a few clicks. It provides the latest analysis techniques for DNA, RNA, Protein, and gene expression, along with effective data management and optimized graphics. It supports customized analysis through various functions such as DNA assembly, Primer design, SNP analysis, RNA secondary structure analysis, Multiple alignment, and plug-in modules.

However, this promotion is limited to students or researchers at non-profit institutions such as universities and academic organizations. Detailed information can be found on Insilicogen’s official website (www.insilicogen.com).

Jung Eun-mi, Chief Experience Officer (CXO) of Insilicogen, stated, “By distributing CLC Main Workbench through this promotion, we aim to provide convenience and usefulness to researchers conducting nucleotide sequence analysis while enhancing user experience. The company will continue to carry out digital transformation campaigns to advance the domestic bioinformatics research field.”